Skip to main content
. 2016 Jan 31;7(10):11056–11066. doi: 10.18632/oncotarget.7090

Figure 3. The mutp53 miRNA signature associates with prognosis of breast and liver cancers.

Figure 3

Comparison of survival in all panels were performed using Kaplan-Meier test. (A–B) Disease-free survival of breast cancers with lymphnode involvement. The subgroups determined by miRNA signature displayed significantly different DFS (A), but the subgroups determined by all miRNAs did not significantly associate with DFS (B). (C–D) Survival of patients in 3 subgroups of liver cancer patients classified by the mutp53 miRNA signature (C) or all miRNAs (D). (E–F) The comparison of patient survival in 4 subgroups determined based on miRNA signature (E) or all miRNAs (F).